Study details
Enrolling now
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
Patricia Suppes
NCT IDNCT05837845ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
30
Study length
about 2.9 years
Ages
18+
Locations
1 site in CA
About this study
Researchers are testing whether MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) is more effective than Cognitive Processing Therapy (CPT) in treating PTSD. The trial will compare these two treatments to see which one works best for veterans with severe PTSD.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Cognitive Processing Therapy
- 2.Participate in MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT)
- 3.Take MDMA
PhasePhase 2
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug routes
oral
Endpoints
Secondary: Change in Quality of Life Enjoyment and Satisfaction Questionnaire
Body systems
Psychiatry / Mental Health